Impact of Using Cow’s Milk Formula During the First Three Postnatal Days and Other Etiological Factors on the Development of Cow’s Milk Protein Allergy
Journal of Clinical Medicine · 07.12.2025 · 14 (24) · 8664
DOI: 10.3390/jcm14248664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.12.2025. Verfasst von Halil Sağır und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Iz…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Early cow’s milk formula (CMF) exposure in the neonatal period has been proposed as a risk factor for cow’s milk protein allergy (CMPA), although evidence remains inconsistent. This study evaluated the association between CMF use within the first 72 h and later CMPA.
Methods
This retrospective study included 106 CMPA infants and 106 controls. CMPA was diagnosed according to ESPGHAN 2024 guidelines using clinical assessment, a 2–4-week elimination diet, and a supervised oral food challenge. Demographic and feeding data were collected, and logistic regression identified independent predictors.
Results
Early CMF exposure was more common in the CMPA group (76% vs. 59%; p = 0.006). Multivariate analysis confirmed early CMF exposure as an independent risk factor (aOR: 2.35; 95% CI: 1.18–4.68). A subgroup with CMF intake limited to the first 72 h followed by exclusive breastfeeding was markedly overrepresented among CMPA cases (47% vs. 12%; p < 0.001). Early CMF exposure did not significantly impact IgE versus non-IgE phenotype distribution. Family history of atopy also remained a strong predictor.
Conclusions
Early CMF exposure during the first 72 h and family history of atopy were key risk factors for CMPA. Supporting breastfeeding initiation and avoiding unnecessary early CMF supplementation may help reduce CMPA incidence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Türkiye.
- Department of Pediatric Gastroenterology, Hepatology and Nutrition, Izmir City Hospital, 35540 Izmir, Türkiye.
ORCID-Profile: Halil Sağır, Yeliz Çağan Appak, Betül Aksoy, Sinem Kahveci, Şenay Onbaşı Karabağ, Özlem Gülpınar Aydın, Serenay Alaca, Maşallah Baran
Zitieren
APA
Sağır, H., Çağan Appak, Y., Aksoy, B., Kahveci, S., Onbaşı Karabağ, Ş., Gülpınar Aydın, Ö., Alaca, S., & Baran, M. (2025). Impact of Using Cow’s Milk Formula During the First Three Postnatal Days and Other Etiological Factors on the Development of Cow’s Milk Protein Allergy. Journal of Clinical Medicine, 14(24), 8664. https://doi.org/10.3390/jcm14248664
Vancouver
Sağır H, Çağan Appak Y, Aksoy B, Kahveci S, Onbaşı Karabağ Ş, Gülpınar Aydın Ö, et al. Impact of Using Cow’s Milk Formula During the First Three Postnatal Days and Other Etiological Factors on the Development of Cow’s Milk Protein Allergy. Journal of Clinical Medicine. 2025;14(24):8664. doi:10.3390/jcm14248664
BibTeX
@article{Sar2025,
author = {Sağır, Halil and Çağan Appak, Yeliz and Aksoy, Betül and Kahveci, Sinem and Onbaşı Karabağ, Şenay and Gülpınar Aydın, Özlem and Alaca, Serenay and Baran, Maşallah},
title = {Impact of Using Cow’s Milk Formula During the First Three Postnatal Days and Other Etiological Factors on the Development of Cow’s Milk Protein Allergy},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {24},
pages = {8664},
doi = {10.3390/jcm14248664}
}
EUVIMED